7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Lymphatic Metastasis D008207 10 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Prediabetic State D011236 1 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hepatitis C D006526 7 associated lipids
Sclerosis D012598 5 associated lipids
Hyperostosis D015576 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Wang Y et al. Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. 2012 Acta Biochim. Biophys. Sin. (Shanghai) pmid:22427460
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Udomsuk L et al. Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. 2012 Fitoterapia pmid:23041523
Yang Y et al. [Association between osteoprotegerin gene polymorphisms and severe pre-eclampsia in Chinese women]. 2012 Zhonghua Fu Chan Ke Za Zhi pmid:22455689
Xiang G et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. 2012 Exp. Clin. Endocrinol. Diabetes pmid:23070830
Lekva T et al. TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover. 2012 Eur. J. Endocrinol. pmid:22450549
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Chaves MD et al. Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. 2012 J Craniomaxillofac Surg pmid:22513050
Koole D et al. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22516062
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Boumans MJ et al. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. 2012 Ann. Rheum. Dis. pmid:22072013
Chen X et al. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. 2012 Biol Trace Elem Res pmid:22076734
Robinson DE et al. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. 2012 Biomaterials pmid:22079008
Aliprantis AO et al. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. 2012 FASEB J. pmid:22125315
Al-Sabbagh M et al. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. 2012 J. Periodont. Res. pmid:22126530
Janda K et al. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. 2012 Prz. Lek. pmid:23750431
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Marzaioli V et al. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. 2012 Arthritis Rheum. pmid:22674155
Tanaka M et al. Effect of Reveromycin A on experimental tooth movement in OPG-/- mice. 2012 J. Dent. Res. pmid:22674934
Yan J et al. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. 2012 Am. J. Pathol. pmid:22640808
Kim S et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. 2012 Diagn. Microbiol. Infect. Dis. pmid:22647538
Jørgensen L et al. Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. 2012 Int J Epidemiol pmid:22538253
Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. 2012 Int. J. Cardiol. pmid:22592030
Güncü GN et al. Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. 2012 Cytokine pmid:22592038
Santos VR et al. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. 2012 J. Periodont. Res. pmid:21806617
Oelzner P et al. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. 2012 Rheumatol. Int. pmid:20821212
Vasconcelos AC et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. 2012 J. Oral Pathol. Med. pmid:22417074
Hwang JJ et al. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. 2012 J. Acquir. Immune Defic. Syndr. pmid:22842843
Liang W et al. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. 2012 Int. J. Mol. Med. pmid:22842877
Nanda KS et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. 2012 Cytokine pmid:22863720
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Fossmark R et al. Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. 2012 J. Cell. Biochem. pmid:21882222
Oka H et al. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. 2012 J. Periodontol. pmid:21910594
Korzon-Burakowska A et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. 2012 Diabet. Med. pmid:21913967
Altan BA et al. Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. 2012 Lasers Med Sci pmid:21038101
Banfi G et al. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. 2012 J Sports Med Phys Fitness pmid:22525657
Wilkison M et al. Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. 2012 Am. J. Pathol. pmid:22626807
Wang QP et al. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. 2012 Bone pmid:22634178
Brunetti G et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. 2012 Endocrine pmid:22638612
Lacey DL et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. 2012 Nat Rev Drug Discov pmid:22543469
Campia U et al. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. 2012 Heart pmid:22543836
Choe WS et al. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. 2012 J. Genet. pmid:22546829
Bloch SL et al. The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. 2012 Anat Rec (Hoboken) pmid:22577084
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Canon J et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. 2012 Breast Cancer Res. Treat. pmid:22926264
Shuid AN et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. 2012 BMC Complement Altern Med pmid:22967165
Dougall WC Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. 2012 Clin. Cancer Res. pmid:22031096
Sakai N et al. Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. 2012 Hepatology pmid:22031462
Sanchez C et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. 2012 Arthritis Rheum. pmid:22034083
Rimondi E et al. Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 2012 Invest New Drugs pmid:21541705
Li YQ et al. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. 2012 Acta Pharmacol. Sin. pmid:22120966
Babür C et al. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis. 2012 J Dent pmid:22326720
Bataille C et al. Different sympathetic pathways control the metabolism of distinct bone envelopes. 2012 Bone pmid:22326888
Taylor RM et al. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. 2012 Lab. Invest. pmid:22330339
Wei W et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22315431
Hulin-Curtis SL et al. Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. 2012 Int. J. Immunogenet. pmid:22296645
Fitzgerald O and Chandran V Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012 J. Rheumatol. pmid:22298273
Silva JA et al. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. 2012 Cells Tissues Organs (Print) pmid:22301390
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Feng G et al. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women. 2012 J. Pediatr. Endocrinol. Metab. pmid:23329761
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Tyagi AM et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. 2012 PLoS ONE pmid:22970248
Kadoglou NP et al. Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. 2012 Regul. Pept. pmid:22982141
Feng Q et al. [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23302383
Yilmaz Y and Eren F Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. 2012 Clin. Chim. Acta pmid:22985537
Yan J et al. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. 2012 J. Cell. Mol. Med. pmid:22947224
Mlakar SJ et al. Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. 2012 Maturitas pmid:22221655
Kadkhodazadeh M et al. Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. 2012 Eur J Oral Implantol pmid:23304691
Curl L et al. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. 2012 Aust Orthod J pmid:23304971
Emanuele E et al. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. 2012 Front Biosci (Elite Ed) pmid:22201906
Karatolios K et al. Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. 2012 Clin. Biochem. pmid:22202560
Kwon SR et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. 2012 Rheumatol. Int. pmid:21833531
Jia P et al. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. 2012 Zhonghua Yi Xue Za Zhi pmid:23158430
Jacot W et al. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. 2012 Breast Cancer Res. Treat. pmid:22562178
Dieset I et al. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. 2012 Schizophr. Res. pmid:22817875
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Kaneko K et al. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. 2012 J. Clin. Endocrinol. Metab. pmid:22791764
Çanga A et al. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. 2012 J Cardiol pmid:22727437
Yoon WJ et al. Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. 2012 Food Chem. Toxicol. pmid:22727857
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Crotti TN et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. 2012 Arthritis Res. Ther. pmid:23146195
Yao Y et al. [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934505
Zhang M et al. [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934488
Tenta R et al. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. 2012 J. Endocrinol. Invest. pmid:21606670
Liu L et al. [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22594224
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Histing T et al. Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. 2012 J. Surg. Res. pmid:21571305
Dey P et al. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. 2012 Mol. Endocrinol. pmid:23028063
Song TJ et al. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. 2012 Biomarkers pmid:23030274
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672
Ostrowska Z et al.  Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. 2012 Postepy Hig Med Dosw (Online) pmid:23001207
Ramirez-Yanez GO and Symons AL Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: an in vitro study. 2012 Arch. Oral Biol. pmid:22480456
Dalbeth N and McQueen FM Clarification of the modified radiographic damage scoring method for gout. 2012 J. Rheumatol. pmid:22467953
Taddei SR et al. Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. 2012 J Biomech pmid:23036306

Table of Content